NICE Overturns Bavencio Rejection After Merck/Pfizer Win Appeal On English Funding

Over 800 People With Urothelial Cancer Set To Benefit From Bavencio

 
• By Neena Brizmohun
  
Fracture bones in osteoporosis - front view 3d illustration
NICE says Evenity will be the first new treatment for osteoporosis for over a decade • Source: Alamy

More from United Kingdom

More from Europe